IBD Performance — Inspire Corporate Bond ETF
Data updated: 2026-07-28
IBD returned +0.42% year to date and +4.71% over one year to May 2026. Annualised returns are +5.15% over 3 years and +1.37% over 5 years. The fund trailed its Intermediate Corporate Bond category average: $100 invested three years ago grew to $116, against $119 for the category, and to $105 over one year, against $106. Volatility over the past three years was 3.81% a year. In the 12 months to May 2026 the fund took in a net $84.3M, and assets reached $466.80M.
IBD Growth of $100
What $100 invested in Inspire Corporate Bond ETF grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Intermediate Corporate Bond category average over the same months.
| Period | IBD | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $105 | $106 |
| 3 years (Jun 2023 – May 2026) | $116 | $119 |
| 5 years (Jun 2021 – May 2026) | $107 | $107 |
| Since data start (Mar 2020 – May 2026) | $109 | $112 |
IBD Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +0.42% |
| 1 year | +4.71% |
| 3 years (annualised) | +5.15% |
| 5 years (annualised) | +1.37% |
IBD Annual Returns
Calendar-year total returns of Inspire Corporate Bond ETF, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +0.42% |
| 2025 | +7.13% |
| 2024 | +3.59% |
| 2023 | +6.41% |
| 2022 | −9.23% |
| 2021 | −1.75% |
| 2020 (Mar–Dec) | +2.98% |
IBD Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.2% | +0.9% | −1.4% | +0.5% | +0.3% | — | — | — | — | — | — | — |
| 2025 | +0.4% | +1.4% | +0.1% | +0.5% | +0.2% | +1.3% | +0.1% | +1.1% | +0.5% | +0.3% | +0.6% | +0.2% |
| 2024 | +0.1% | −1.0% | +0.9% | −1.4% | +1.2% | +0.8% | +1.7% | +1.5% | +1.1% | −1.4% | +0.8% | −0.7% |
| 2023 | +2.1% | −1.8% | +1.5% | +0.8% | −0.6% | −0.4% | +0.6% | −0.1% | −1.3% | −0.9% | +3.5% | +3.0% |
| 2022 | −1.8% | −1.1% | −2.4% | −2.5% | +0.4% | −1.6% | +2.0% | −1.6% | −3.1% | −0.8% | +2.7% | +0.3% |
| 2021 | −0.4% | −1.1% | −1.0% | +0.9% | +0.4% | +0.7% | +0.7% | −0.2% | −0.8% | −0.5% | −0.2% | −0.1% |
| 2020 | — | — | −7.0% | +4.6% | +2.0% | +1.5% | +1.2% | −0.1% | −0.1% | −0.1% | +0.9% | +0.5% |
IBD Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 3.81%
- 3-year Sharpe ratio: 0.17 (vs 4.5% risk-free rate)
- Best month: +3.47% (Nov 2023)
- Worst month: −1.44% (Apr 2024)
IBD Fund Flows
Monthly money in and out of Inspire Corporate Bond ETF, from SEC Form N-PORT.
- 12-month net flow: $84.3M
- 12-month gross sales (incl. reinvestments): $120.1M
- Sales ÷ redemptions: 3.35×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $0 | $0 |
| Apr 2026 | $16.7M | $19.1M | −$2.5M |
| Mar 2026 | $9.6M | $11.9M | −$2.4M |
| Feb 2026 | $2.4M | $0 | $2.4M |
| Jan 2026 | $19.3M | $0 | $19.3M |
| Dec 2025 | $7.2M | $0 | $7.2M |
| Nov 2025 | $9.6M | $0 | $9.6M |
| Oct 2025 | $12.1M | $0 | $12.1M |
| Sep 2025 | $12.1M | $0 | $12.1M |
| Aug 2025 | $14.4M | $0 | $14.4M |
| Jul 2025 | $12.0M | $0 | $12.0M |
| Jun 2025 | $4.7M | $4.8M | −$9K |
IBD Assets Under Management
Net assets of Inspire Corporate Bond ETF by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $466.80M |
| 2026-02-28 | $479.72M |
| 2025-11-30 | $449.53M |
| 2025-08-31 | $413.85M |
| 2025-05-31 | $381.94M |
| 2025-02-28 | $377.77M |
| 2024-11-30 | $332.55M |
| 2024-08-31 | $358.26M |
| 2024-05-31 | $308.73M |
| 2024-02-29 | $251.65M |
| 2023-11-30 | $232.66M |
| 2023-08-31 | $257.48M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.